| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP CLO & General Counsel | EVP Legal & General Counsel | EVP & General Counsel +3 more
1 company
Patrick R. O'Neil is EVP CLO & General Counsel at IONS. From January 2019 to August 2026, the filings on record show 0 open-market purchases and 31 sales. Patrick R. O'Neil's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $2.4M at current prices.
Historically, Patrick R. O'Neil's trades have earned a middling insider score of 63/100 across 26 rated trades. Over a 12-month horizon, 59.1% of those trades were profitable, with an average 12-month return of -9.2%.
The IONS filings lean toward selling, a net 463,394 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2019 | IONS Ionis Pharmaceuticals Inc | SVP Legal & General Counsel | Sale+OE | 4,400 | $54.80 | $241,120.00 | -23.2% |